Have you missed an interesting live webinar? No problem! Below you will find all our previous webinars that you can watch on demand.

You can find more videos on demand in German on our German page.

(Open by clicking on the respective title)

07.02.2022 | CLINICAL MASTERCLASS #6 | Designing trials in critical care

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. Alexandre Mebazaa

View the recording here

The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.

27.01.2022 | State-of-the-art therapy for COVID-19

With Professor Martin Witzenrath, Deputy Director of the Department of Medicine with focus on Infectiology and Pneumology and Head of the Pulmonary Inflammation Unit. He is also responsible for the BMBF-funded PROVID project, which is investigating the prognosis, pathomechanisms and treatment strategies of COVID-19.

What specific therapeutics are available and when should they be used? Are these only for severely ill patients?

On demand on YouTube

11.01.2022 | Update COVID-19 Vaccines

With Professor Leif Erik Sander, Head of the Research Group for Infection Immunology and Vaccine Research at the Medical Clinic with a focus on Infectiology and Pneumology at Charité - Universitätsmedizin Berlin. He has been part of the German government's expert panel on COVID-19 since December 2021.

How well do vaccinations work? When will there be adapted vaccines? How many more vaccines are we likely to need?

On demand on YouTube

10.11.2021 | CLINICAL TRIALS MASTERCLASS #4 | Designing trials in antiplatelet therapy – insights from the TWILIGHT trial

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. Roxana Mehran, New York (USA), an internationally recognized interventional cardiologist and expert in clinical research in cardiovascular disease. A professor of medicine (cardiology) and health science and policy at the Icahn School of Medicine at Mount Sinai, she has established a globally recognized academic research center focused on the development of randomized clinical trials. As principal investigator, she has been involved in numerous global trials. She has developed risk scores for hemorrhage and acute kidney injury, is regularly involved in clinical guideline development, and has authored more than 1,000 peer-reviewed articles.

View the recording here


The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.

04.11.2021 | CLINICAL TRIALS MASTERCLASS #3 | What have we learned from the SGLT2i trials in heart failure?

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. John McMurray, Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. He also serves on the editorial boards of several leading cardiovascular journals, including the European Heart Journal and Circulation. Additionally he served also as the President of the Heart Failure Association of the ESC.

View the recording here

The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.

21.10.2021 | CLINICAL TRIALS MASTERCLASS #2 | What is heart failure? A trialist's perspective

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. John Cleland, UK, one of the leading researchers in the field of heart failureand has led large, international clinical trials to study treatments. He has also been involved in a number of randomized trials  to study interventions for heart failure, including the CARE-HF, PEP-CHF und HeartCycle.

View the recording here

The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.


14.10.2021 | CLINICAL TRIALS MASTERCLASS #1 | Maximising scientific knowledge production from clinical trials

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. Faiez Zannad, Nancy (France), Heart Failure Specialist. Faiez Zannad has made significant contributions to biomarker research. He currently leads two EU-funded programs: www.homage-hf.eu and www.fibrotargets.eu. He was Principal Investigator (PI) of the first outcome trial of a non-vitamin K-dependent oral anticoagulant (NOAK) in heart failure ((COMMANDER-HF-Study) and co-PI of the first outcome trial of glucose-lowering SGLT2 inhibitors (EMPEROR-Reduced-Study) in heart failure. Zannad is a founder of the Global CardioVascular Clinical Trialists Forum (CVCT) .

View the recording here


The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.

 

 

27.07.2021 | SCIENCE ON FRIDAY | Biodatabases of the DZHK – Design, methods and examples of use

Chairs: H. Schunkert (Munich), P. Wild (Mainz)

Recording only for DZHK members on the intranet (login required). Watch here

23.04.2021 | SCIENCE ON FRIDAY | In vitro and large animal models for cardiovascular disease

Chair: C. Kupatt (Munich)

Recording only for DZHK members on the intranet (login required). Watch here

19.03.2021 | SCIENCE ON FRIDAY | Heart failure with preserved ejection fraction: What’s new in the DZHK?

Chairs: B. Pieske (Berlin), J. Heineke (Mannheim), D. Westermann (Hamburg)

Recording only for DZHK members on the intranet (login required). Watch here

19.02.2021 | SCIENCE ON FRIDAY | Artifical Intelligence in Cardiovascular Research

Chair: Alexander Meyer, Deutsches Herzzentrum Berlin (DHZB)

Recording only for DZHK members on the intranet (login required). Watch here

22.01.2021 | SCIENCE ON FRIDAY | Gene Therapy

Chair: Lucie Carrier, University Medical Center Hamburg-Eppendorf

Recording only for DZHK members on the intranet (login required). Watch here

11.12.2020 | SCIENCE ON FRIDAY | Small molecules, RNA therapeutics and biologicals

Chair: Johannes Backs, Heidelberg University Hospital

Recording only for DZHK members on the intranet (login required). Watch here

11.11.2020 | SCIENCE ON FRIDAY | Omics and single-cell technologies

Chair: Norbert Hübner, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

Recording only for DZHK members on the intranet (login required). Watch here

01.12.2021 | CLINICAL TRIALS MASTERCLASS #5 | Designing trials in arrhythmia treatment

Authors and study leaders report on how they conducted their study in the Clinical Trials Masterclass: What was critical in choosing the study design and endpoints? What was their most important learning?

Clinical Trials Masterclass with Prof. Paulus Kirchhof, Hamburg, Director of the Department of Cardiology at the University Heart and Vascular Center UKE Hamburg and holds a part-time position as Professor of Cardiovascular Medicine in the Institute of Cardiovascular Sciences at the University of Birmingham. He researches translational mechanisms and management of cardiovascular diseases with a special interest in atrial fibrillation, cardiomyopathies, and heart failure. His research aims to translate new mechanistic findings into patient benefit, covering mechanistic research, translational studies, and large clinical trials. Professor Kirchhof chairs the Board of AFNET and sits on the Board of the European Society of Cardiology. He also contributes to guidelines, curricula, and textbooks

View the recording here

The masterclass is organized by Young-DZHK members from the Berlin site together with colleagues from the Nuffield Department of Population Health at the University of Oxford.